Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
Nicholas J. Viney, Julian C. van Capelleveen, Richard S. Geary, Shuting Xia, Joseph A. Tami, Rosie Z. Yu, Santica M. Marcovina, Steven G. Hughes, Mark J. Graham, Rosanne M. Crooke, Stanley T. Crooke, Joseph Lee Witztum, Erik S.G. Stroes, Sotirios Tsimikas
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/s0140-6736(16)31009-1
- Published
- Sep 21, 2016
- Venue
- The Lancet
- DOI
- 10.1016/s0140-6736(16)31009-1
- PubMed
- 27665230
- Categories
- Lipoproteins and Cardiovascular Health
- Provenance
- openalex